Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
To Characterize the Clinical Presentation of C-Vam/To Contrast C-Vam with Cardiac Complications of Infection with Sars-… is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by New York Medical College. Estimated value $2.6M ($2.6M obligated). Current period of performance ends Sep 27, 2027. Last award drew 165 bidders. Place of performance: SILVER SPRING MD.
To characterize the clinical presentation of c-vam/to contrast c-vam with cardiac complications of infection with sars-cov-2 that the immunization seeks to prevent/to inform best practices for surveillance and monitoring for c-vam, including in asymp. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 27, 2027 (345 days remaining). Agencies typically plan 12–18 months ahead — at 11.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75F40122C00148? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNew York Medical College — $3.3M obligated across 16 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122C00148?
75F40122C00148 (Characterize the clinical presentation of c-vam) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.6M, currently held by New York Medical College. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122C00148?
Fda Office Of Acq Grant Svcs awarded 75F40122C00148 to New York Medical College (potential $2.6M).
Who is the incumbent on 75F40122C00148?
New York Medical College is the incumbent with $3.3M across 16 related awards in SCOUT’s public footprint. The current period of performance ends Sep 27, 2027.
When does New York Medical College’s 75F40122C00148 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 27, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40122C00148? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.